Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Insmed Inc. (IM8N)
Market Closed
17 Jul, 20:00
XFRA
All
(8)
DE
(4)
IT
(1)
MX
(1)
GB
(1)
US
(1)
NASDAQ (NGS)
Primary
LSE
XFRA
XSTU
XMEX
XDUS
XMIL
XETRA
93.
16
-2.42
-2.5319%
20.28B
Market Cap
-
P/E Ratio
-
Div Yield
10
Volume
-5.21
Eps
95.58
Previous Close
Watching
Watch
Add Transaction
Day Range
93.16
93.16
Year Range
78.77
185
Want to track
IM8N
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Insmed Inc. (IM8N) Statistics
Valuation metrics
Market Cap
20.28B
Enterprise value
17.02B
Trailing P/E (ttm)
-14.57
Forward P/E
-29.05
PEG ratio
0.31
Price/Sales (ttm)
24.74
Price/Book (mrq)
33.41
Enterprise Value/Revenue
24.15
Enterprise Value/EBITDA
-20.86
Overview
Shares outstanding
216.52M
Float
198.31M
Shares short
-
% Held by insiders
0.01%
% Held by institutions
1.05%
Average volume (10 days)
141
Average volume (90 days)
131
Price summary
52-Week low
78.77
52-Week high
185
Beta
0.89
50-Day moving average
118.43
200-Day moving average
134.38
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:10
Last split Date
3 Mar 2011
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-1.44%
Operating margin
-0.65%
Operational effectiveness
Return on assets
-0.31%
Return on equity
-2.94%
Income Statement
Revenue (ttm)
704.49M
Revenue per share (ttm)
3.95
Quarterly revenue growth (yoy)
2.3%
Gross profit (ttm)
576.34M
EBITDA
-815.78M
Net income to common (ttm)
-1.02B
Diluted EPS (ttm)
-4.96
Quarterly earnings growth (yoy)
2.3%
Balance Sheet
Total cash (mrq)
1.05B
Total cash per share (mrq)
5.64
Total debt (mrq)
638.21M
Total Debt/Equity (mrq)
105.34
Current ratio (mrq)
4.47%
Book value per share (mrq)
2.8
Cash Flow
Cash flow statement
-769.9M
Levered free cash flow (LFCF)
-521.09M